Companies: 10,795·Total market cap: $144.5T
Spectral Medical Inc.

Spectral Medical Inc.

EDT.TOTSXHealthcare● Active
$1.38
+$0.00(+0.00%)
Market Cap$404918208
P/E Ratio
52W High$1.84
52W Low$0.77
Overview

Spectral Medical Inc. (EDT.TO) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

edt.to · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Spectral Medical Inc. (EDT.TO) measures how much investors pay for each dollar of the company's trailing earnings. EDT.TO's current PE ratio of N/A is calculated by dividing its stock price of $1.38 by its TTM earnings per share of -$0.13.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
N/A
Based on 1 analyst
EPS (TTM)
-$0.13
TTM · diluted EPS
PEG Ratio
0.11
Below 1.0 · Growth adjusted
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Spectral Medical Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-08

PE Ratio History

2006 – 2025 · Annual
PE Ratio (TTM)
5Y Avg 5.2x
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Diagnostics & Research · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Spectral Medical Inc.
Spectral Medical Inc.You
EDT.TO
$405MN/A-$0.13
Aurora Cannabis Inc.
Aurora Cannabis Inc.
ACB.TO
$274M217.30x+91.2%$0.03
Cresco Labs Inc.
Cresco Labs Inc.
CL.CN
$457MN/A-$0.40
Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc.
CPH.TO
$429M10.05x-91.2%$1.09
Eupraxia Pharmaceuticals Inc.
Eupraxia Pharmaceuticals Inc.
EPRX.TO
$305MN/A-$0.98
Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc.
FRX.TO
$356MN/A-$0.36
High Tide Inc.
High Tide Inc.
HITI.V
$292MN/A-$0.62
Industry Average
2 peers with valid PE
113.68xbaseline

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 10 of 20 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
$-0.17
2024-12-31
FY2024
$-0.05
2023-12-31
FY2023
$-0.06
2022-12-31
FY2022
$-0.04
2021-12-31
FY2021
$-0.03
2020-12-31
FY2020
$-0.04
2019-12-31
FY2019
$-0.02
2018-12-31
FY2018
$-0.01
2017-12-31
FY2017
$-0.02
2016-12-31
FY2016
$-0.05

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Spectral Medical Inc. (EDT.TO) measures how much investors pay for each dollar of the company's trailing earnings. EDT.TO's current PE ratio of N/A is calculated by dividing its stock price of $1.38 by its TTM earnings per share of -$0.13.

PE Ratio = Stock Price ÷ EPS (TTM)
= $1.38 ÷ -$0.13 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

EDT.TO pe ratio · 6 questions

EDT.TO's current PE ratio is N/A as of 2026-06-08, based on a stock price of $1.38 and TTM EPS of -$0.13. Data sourced from Financial Modeling Prep via EDT.TO's SEC 10-K and 10-Q filings.

EDT.TO PE ratioWhat is EDT.TO PE ratioCurrent PE ratio of EDT.TOEDT.TO PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Spectral Medical Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08